222 related articles for article (PubMed ID: 11858641)
1. Molecular modelling of the differential interaction between several non-steroidal anti-inflammatory drugs and human prostaglandin endoperoxide H synthase-2 (h-PGHS-2).
Pouplana R; Lozano JJ; Ruiz J
J Mol Graph Model; 2002 Jan; 20(4):329-43. PubMed ID: 11858641
[TBL] [Abstract][Full Text] [Related]
2. Structure-based QSAR study on differential inhibition of human prostaglandin endoperoxide H synthase-2 (COX-2) by nonsteroidal anti-inflammatory drugs.
Pouplana R; Lozano JJ; Pérez C; Ruiz J
J Comput Aided Mol Des; 2002 Oct; 16(10):683-709. PubMed ID: 12650588
[TBL] [Abstract][Full Text] [Related]
3. The structural and electronical factors that contribute affinity for the time-dependent inhibition of PGHS-1 by indomethacin, diclofenac and fenamates.
Pouplana R; Pérez C; Sánchez J; Lozano JJ; Puig-Parellada P
J Comput Aided Mol Des; 1999 May; 13(3):297-313. PubMed ID: 10216835
[TBL] [Abstract][Full Text] [Related]
4. The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs.
Greig GM; Francis DA; Falgueyret JP; Ouellet M; Percival MD; Roy P; Bayly C; Mancini JA; O'Neill GP
Mol Pharmacol; 1997 Nov; 52(5):829-38. PubMed ID: 9351974
[TBL] [Abstract][Full Text] [Related]
5. Involvement of arginine 120, glutamate 524, and tyrosine 355 in the binding of arachidonate and 2-phenylpropionic acid inhibitors to the cyclooxygenase active site of ovine prostaglandin endoperoxide H synthase-1.
Bhattacharyya DK; Lecomte M; Rieke CJ; Garavito M; Smith WL
J Biol Chem; 1996 Jan; 271(4):2179-84. PubMed ID: 8567676
[TBL] [Abstract][Full Text] [Related]
6. Automated docking and molecular dynamics simulations of nimesulide in the cyclooxygenase active site of human prostaglandin-endoperoxide synthase-2 (COX-2).
García-Nieto R; Pérez C; Gago F
J Comput Aided Mol Des; 2000 Feb; 14(2):147-60. PubMed ID: 10721503
[TBL] [Abstract][Full Text] [Related]
7. Interactions of some PGHS-2 selective inhibitors with the PGHS-1: an automated docking study by BioDock.
Pedretti A; Villa AM; Villa L; Vistoli G
Farmaco; 1997; 52(6-7):487-91. PubMed ID: 9372601
[TBL] [Abstract][Full Text] [Related]
8. Arginine 120 of prostaglandin G/H synthase-1 is required for the inhibition by nonsteroidal anti-inflammatory drugs containing a carboxylic acid moiety.
Mancini JA; Riendeau D; Falgueyret JP; Vickers PJ; O'Neill GP
J Biol Chem; 1995 Dec; 270(49):29372-7. PubMed ID: 7493972
[TBL] [Abstract][Full Text] [Related]
9. Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid.
Chulada PC; Langenbach R
J Pharmacol Exp Ther; 1997 Feb; 280(2):606-13. PubMed ID: 9023270
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of the dynamic mechanism of ligand binding to cyclooxygenase.
Llorens O; Perez JJ; Palomer A; Mauleon D
Bioorg Med Chem Lett; 1999 Oct; 9(19):2779-84. PubMed ID: 10522690
[TBL] [Abstract][Full Text] [Related]
11. On the interaction of specific prostaglandin H synthase-2 inhibitors with prostaglandin H synthase-1.
Burde T; Rimon G
Eur J Pharmacol; 2002 Oct; 453(2-3):167-73. PubMed ID: 12398900
[TBL] [Abstract][Full Text] [Related]
12. Differential binding mode of diverse cyclooxygenase inhibitors.
Llorens O; Perez JJ; Palomer A; Mauleon D
J Mol Graph Model; 2002 Mar; 20(5):359-71. PubMed ID: 11885959
[TBL] [Abstract][Full Text] [Related]
13. Docking studies on NSAID/COX-2 isozyme complexes using contact statistics analysis.
Ermondi G; Caron G; Lawrence R; Longo D
J Comput Aided Mol Des; 2004 Nov; 18(11):683-96. PubMed ID: 15865061
[TBL] [Abstract][Full Text] [Related]
14. Selective PGHS-2 inhibitors: a rational approach for treatment of the inflammation.
Rodrigues CR; Veloso MP; Verli H; Fraga CA; Miranda AL; Barreiro EJ
Curr Med Chem; 2002 Apr; 9(8):849-67. PubMed ID: 11966448
[TBL] [Abstract][Full Text] [Related]
15. PGHS-2 inhibitors, NS-398 and DuP-697, attenuate the inhibition of PGHS-1 by aspirin and indomethacin without altering its activity.
Rosenstock M; Danon A; Rimon G
Biochim Biophys Acta; 1999 Aug; 1440(1):127-37. PubMed ID: 10477832
[TBL] [Abstract][Full Text] [Related]
16. Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs.
Smith WL; DeWitt DL
Semin Nephrol; 1995 May; 15(3):179-94. PubMed ID: 7631045
[TBL] [Abstract][Full Text] [Related]
17. Arachidonic acid and nonsteroidal anti-inflammatory drugs induce conformational changes in the human prostaglandin endoperoxide H2 synthase-2 (cyclooxygenase-2).
Smith T; McCracken J; Shin YK; DeWitt D
J Biol Chem; 2000 Dec; 275(51):40407-15. PubMed ID: 11006278
[TBL] [Abstract][Full Text] [Related]
18. Theoretical studies on the inhibition mechanism of cyclooxygenase-2. Is there a unique recognition site?
Soliva R; Almansa C; Kalko SG; Luque FJ; Orozco M
J Med Chem; 2003 Apr; 46(8):1372-82. PubMed ID: 12672237
[TBL] [Abstract][Full Text] [Related]
19. Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs.
Patrignani P; Panara MR; Sciulli MG; Santini G; Renda G; Patrono C
J Physiol Pharmacol; 1997 Dec; 48(4):623-31. PubMed ID: 9444611
[TBL] [Abstract][Full Text] [Related]
20. The structures of prostaglandin endoperoxide H synthases-1 and -2.
Garavito RM; Malkowski MG; DeWitt DL
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():129-52. PubMed ID: 12432914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
